Professional Documents
Culture Documents
conference
May 26th, 2016
Case presentation
A Thai male 33-year-old
History taking ?
Visual loss
Change in appearance of eye
Eye pain/discomfort
Trauma: Mechanism
Circumstances surrounding
the onset
Painful/painless
Characteristic of pain: aching,
burning, throbbing
Pruritus
FB sensation
Flashing light
Past history
Previous surgery
Contact lens
Chronic use of certain
ophthalmic medications
History of diabetes, HT
Previous similar symptoms
and associated diagnosis
History taking
12 hr PTA, after drinking alcohol (bootleg whisky), he
complained to his mother that his vision decreased
bilaterally. His mother told him to sleep for a while.
10 min PTA, He developed severe back pain. His
consciousness was good. He denied history of back
trauma. His vision progressively decreased at that time
His mother stated that he was agitation and sweat out
over extremities. He also put his hands on the chest.
At the emergency room, he was restless and excessive
sweating
Physical examination
V/S: BP 158/105 mmHg
HR 115 bpm
RR 30 /min
SpO2 99 %
BT 36 c
HEENT: No pale conjunctivae, anicteric sclerae,
cervical LN cant be palpated, no jugular venous
distension, no carotid bruit
Lungs: clear and equal breath sound
Heart: Regular tachycardia, normal S1S2, no murmur
Abdomen: normoactive bowel sound, soft, no
tenderness
Physical examination
During a neurological examination
He was drowsiness and
unresponsed
Re-assessment
A: Air hunger
B: RR 36 /min, SpO2 90%
lungs: clear and equal BS
C: BP 170/110 mmHg, HR 120 bpm, CRT 1 sec
warm extremities
D: E1V1M4 pupil 4 mm SRTLBE
CXR portable
Whats next ?
Neurological assessment
in coma patient
CPOMR
Consciousness: normal, confused, drowsy, stuporous, semicoma, coma
Pupils
Ocular movement and eyelids
Primary position
Spontaneous/reflex eye movement
Motor system
Limb position, spontaneous movement
Seizure activity
Muscle tone, motor response, posture
Respiration
In this patient
C: Drowsiness, E4VTM5
P: Pupil 4 mm SRTLBE
O: Eye opening, Spontaneous eye movement,
midline primary position, Intact Dolls eye sign
M: Spontaneous equal movement, Motor
power at least Gr. III all
R: Normal pattern but hyperventilation
Stroke/TIA
Seizure/Post-ictal phase
SAH
Intracranial hemorrhage
CNS mass lesion
Subdural hematoma
Meningitis/Encephalitis
Extracranial
Hypo/hyperglycemia
Toxic alcohols
Electrolyte abnormalities
Hepatic/Uremic encephalopathy
Thyroid disorders
Hypoxia/Acidosis
Environment: hypo/hyperthermia
CT brain (non-contrast)
CT brain (non-contrast)
FINDINGS: The study shows
- Normal attenuation of brain parenchyma without focal lesion.
- Normal appearance of ventricular system, cisterns and cortical
sulci.
- No shift of the midline structures.
- Mucosal thickening in right maxillary sinus. A dome shape soft
tissue lesion in right sphenoid sinus is likely to be mucosal retention
cyst. The remaining PNSs and bilateral mastoid air cells appear
normal.
- The bony calvaria are intact.
IMPRESSION:
- No evidence of intracranial hemorrhage or large territorial
infarction.
Laboratory investigation
Laboratory investigation
Laboratory investigation
Laboratory investigation
UA
12-lead EKG
- Delta ratio =
=
=
= 1.1
3
245
19
Pure high-gap metabolic acidosis
- Calculated osmolarity = 2[Na] +
= 2(142) +
196
18
6
0.8
18
0.8
= 302.3
Diagnosis
Severe high gap metabolic acidosis from
methanol intoxication
DDx. Lactic acidosis, AKA
AKI
Acute visual loss suspected from methanol
intoxication
Management
Bicarbonate administration (at ED total 300 ml
of 7.5% NaHCO3)
IV fluid
5% D/NSS/2 iv 60 ml/hr
NSS 80 ml/hr
Case progression
Extubation 2 days after admission
Consult
ophthalmologist
at ward for exam
Case progression
Case progression
Methanol
Intoxication
Outline
Mechanism and clinical features
Options for treatment
High-gap metabolic acidosis
Methanol
Clinical features
CNS depression: headache, vertigo, dizziness,
seizures, coma
Metabolic acidosis: tachypnea, shortness of
breath to compensate
Visual impairment: photophobia, blurred or
snow field vision, papilledema
Optic neuropathy, Putamen necrosis
Delayed parkinsonism, polyneuropathy
CVS: tachycardia, hypotension
GI: Abd pain, N/V, mild transaminitis
Etc: Rhabdomyolysis, renal failure
Clinical features
Treatment
Three treatment goals
1. Correction of metabolic acidosis with
bicarbonate
2. ADH enzyme blockade, inhibits the
metabolism to toxic metabolites
3. Removal of the parent alcohol and its
metabolite
Metabolic blockade
Fomepizole
Initial dose: 15 mg/kg IV
over 30 min
Followed by 10 mg/kg IV
over 30 min q 12 hr
Until methanol level <6
mmol/L
More frequent dose if
hemodialysis (q 4 hr)
Less S/E: mild nausea,
headache, dizziness
Ethanol
Can be administered IV/PO
Maintain target ethanol
level of 100-150 mg/dL
Monitor serum ethanol q
1-2 hr
Dosing varies depending
on patients baseline
ethanol use
Hemodialysis
Adjunctive therapy
Vitamin B (including folate)
References